Skip to main content

Closed

RLAY: Relay Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-60.8% / yr

Operating margin-2776.6%

ROIC-44.0%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage0.0×

Current ratio22.13×

Relay Therapeutics, Inc.

RLAYNASDAQ Global Market·USD·Closed

Relay Therapeutics, Inc.

RLAYNASDAQ·USD·Closed

$18.83

−3.19%

$18.83

−$0.62 (3.19%)

52W Range

89thpctl

Volume

0.43×avg

Mkt Cap

3.30BUSD

P/E

-12.0TTM

Div Yield

–ann

52W Range

89thpctl

Volume

0.43×avg

Market Cap

3.30BUSD

P/E Ratio

-12.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings